echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medicines Company News > Fosun and Yuyuan Co., Ltd. enter into equity and creditor's rights transfer contract

    Fosun and Yuyuan Co., Ltd. enter into equity and creditor's rights transfer contract

    • Last Update: 2021-07-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Fosun Pharma issued an announcement stating that on April 26, 2021, the company's subsidiary Chancheng Hospital as the seller, Fosun Medical as the seller, and Fosun Chanxi as the target company as the buyer, entered into a transfer contract with Yuyuan shares as the buyer
    .


    Accordingly, Chancheng Hospital and Fosun Medical agreed to transfer and sell the equity to Yuyuan Co.


    After the completion of the disposal, Yuyuan (or its affiliated company designated in accordance with the agreement) will hold 100% of Foshan Chanxi, and Fosun Chanxi will cease to be a subsidiary of Fosun Pharma
    .


    According to the information, Foshan Chanxi is a limited liability company established in the PRC.


    The announcement shows that in order to meet the development needs of Chancheng Hospital and give play to its medical advantages and radiation demonstration role in South China, in August 2018, the company was approved by the 69th meeting of the seventh board of directors and agreed to promote the construction and implementation of the "Zen Medical Health City".
    Complex project"
    .


    Since the land involved in the project is a mixed land for medical and health, social welfare, and compatible with Class II residential land and commercial and commercial land, the land use right is an integral bid, auction, listing and cannot be divided, so a specially established project company (I.


    In view of the fact that part of the commercial and residential real estate business in Foshan Chanxi "Zen Medical Health City Complex Project" has nothing to do with the main business of the group, but Chancheng Hospital and Foshan Chanxi have used the project to operate women and children's medical centers and nursing homes.
    The relevant properties of the company have signed a customized agreement, agreeing to deliver the customized project to Chancheng Hospital in a timely manner after the completion of the completion of the acceptance and filing of the customized project, and to transfer the property rights of the customized project to the name of Chancheng Hospital by means of asset transfer
    .


    Therefore, in order to focus on the main business, the group intends to transfer the equity of Foshan Chanxi as a whole


    Entering into a transfer contract to provide medical facilities for the key expansion and development of the Women’s and Children’s Medical Center and Nursing Home of Chancheng Hospital, to further develop its professional characteristics and advantages to meet the increasing demand for high-end medical services in the Greater Bay Area, and also to help the group focus Main business


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.